Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001700873 | SCV002438157 | benign | not provided | 2024-01-17 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002458562 | SCV002737504 | benign | Cardiovascular phenotype | 2019-09-13 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV001700873 | SCV004137536 | likely benign | not provided | 2022-11-01 | criteria provided, single submitter | clinical testing | ALPK3: BP4 |
Breakthrough Genomics, |
RCV001700873 | SCV005292002 | benign | not provided | criteria provided, single submitter | not provided | ||
Clinical Genetics, |
RCV001700873 | SCV001919526 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001700873 | SCV001973082 | likely benign | not provided | no assertion criteria provided | clinical testing |